Wealthspire Advisors (New York)’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,557
Closed -$250K 493
2020
Q1
$250K Buy
+2,557
New +$250K 0.01% 431